T0	Participants 87 115	nonresectable rectal cancer:
T1	Participants 241 271	locally advanced rectal cancer
T2	Participants 451 584	Patients (N = 207) with nonresectable rectal cancer were randomized to preoperative CRT or RT (2 Gy × 25 ± 5-fluorouracil/leucovorin)
T3	Participants 983 1069	the 105 patients alive in Norway and Sweden after 4 to 12 years of follow-up, 78 (74%)
T4	Participants 1402 1433	Of 44 patients in the CRT group
T5	Participants 1860 1894	for locally advanced rectal cancer